SNCA and Parkinson disease: Preventing or reversing the pathological misfolding and self-association of α-synuclein (αSN) can rescue a broad spectrum of pathological cellular insults that manifest in Parkinson’s disease (PD), dementia with Lewy bodies, multiple systems atrophy, and other alpha-synucleinopathies1–9.